SFCM
AXSM icon

Seven Fleet Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Seven Fleet Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.06M Buy
28,826
+14,771
+105% +$3.2M 1.16% 20
2026
Q1 		$2.38M Buy
14,055
+1,100
+8% +$190K 0.75% 35
2025
Q4 		$2.37M Buy
+12,955
New +$1.81M 1.6% 10

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Seven Fleet Capital Management's AXSM Position: Q2 2026 in Review

Seven Fleet Capital Management increased its Axsome Therapeutics (AXSM) stake by 105% in Q2 2026, buying an estimated $3.2M and bringing the position to 28,826 shares worth $7.06M. The position accounts for 1.16% of the portfolio, ranked #20.

Seven Fleet Capital Management first reported a position in AXSM in Q4 2025 and has held it in 3 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Seven Fleet Capital Management held 28,826 shares of Axsome Therapeutics worth $7.06M as of Q2 2026.
  • Seven Fleet Capital Management bought 14,771 Axsome Therapeutics shares in Q2 2026, an estimated $3.2M.
  • Axsome Therapeutics made up 1.16% of Seven Fleet Capital Management's portfolio in Q2 2026, its #20 holding.
  • Seven Fleet Capital Management first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.